Newsbenzinga
Definium Therapeutics Says Unprecedented Efficacy From Anxiety Study 'Raises the Bar'
· Published
Article summary
Definium Therapeutics says positive Phase 3 trial results for DT120, shows significant and rapid symptom improvement in anxiety participants.
An excerpt from the original article.
Comments —
Loading comments…